Casdin Capital, Llc - Net Worth and Insider Trading

Over the past 18 months, Casdin Capital, Llc made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 130,366 shares made by Aby J. Mathew , a net sale of 54,160 shares made by Todd Berard , and a net sale of 41,634 shares made by Sarah Aebersold .

In summary, during the past 3 months, insiders sold 97,205 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 97,205 shares. During the past 18 months, 378,768 shares of BioLife Solutions Inc (BLFS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 378,768 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net purchase of 299,286 shares made by Anthony G. Quinn , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,719 shares of Generation Bio Co (GBIO) were sold and 762,246 shares were bought by its insiders, resulting in a net purchase of 755,527 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,618 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 498 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 498 shares. During the past 18 months, 5,618 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 37,742 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made no insider transaction in Standard BioTools Inc (LAB). Other recent insider transactions involving Standard BioTools Inc (LAB) include a net purchase of 14,419,404 shares made by Casdin Partners Master Fund, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Standard BioTools Inc (LAB) in total and bought 4,820,959 shares, with a net purchase of 4,820,959 shares. During the past 18 months, 0 shares of Standard BioTools Inc (LAB) were sold and 14,419,404 shares were bought by its insiders, resulting in a net purchase of 14,419,404 shares.

Standard BioTools Inc (LAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made no insider transaction in MaxCyte Inc (MXCT). Other recent insider transactions involving MaxCyte Inc (MXCT) include a net sale of 56,000 shares made by John Joseph Johnston , a net sale of 143,067 shares made by Stanley C Erck , and a net sale of 99,999 shares made by Thomas M. Ross .

In summary, during the past 3 months, insiders sold 8,503 shares of MaxCyte Inc (MXCT) in total and bought 0 shares, with a net sale of 8,503 shares. During the past 18 months, 462,035 shares of MaxCyte Inc (MXCT) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 362,035 shares.

MaxCyte Inc (MXCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made no insider transaction in Absci Corp (ABSI). Other recent insider transactions involving Absci Corp (ABSI) include a net sale of 3,100,000 shares made by Phoenix Venture Partners Ii Lp , a net purchase of 222,222 shares made by Redmile Group, Llc , and a net sale of 19,859 shares made by Zachariah Jonasson .

In summary, during the past 3 months, insiders sold 0 shares of Absci Corp (ABSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,119,859 shares of Absci Corp (ABSI) were sold and 222,222 shares were bought by its insiders, resulting in a net sale of 2,897,637 shares.

Absci Corp (ABSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made no insider transaction in Tenaya Therapeutics Inc (TNYA). Other recent insider transactions involving Tenaya Therapeutics Inc (TNYA) include a net sale of 25,847 shares made by Faraz Ali , a net sale of 21,326 shares made by Whittemore Tingley , and a net sale of 14,550 shares made by Timothy Hoey .

In summary, during the past 3 months, insiders sold 19,621 shares of Tenaya Therapeutics Inc (TNYA) in total and bought 71,428,568 shares, with a net purchase of 71,408,947 shares. During the past 18 months, 74,027 shares of Tenaya Therapeutics Inc (TNYA) were sold and 75,873,012 shares were bought by its insiders, resulting in a net purchase of 75,798,985 shares.

Tenaya Therapeutics Inc (TNYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Capital, Llc made 5 insider transaction in GeneDx Holdings Corp (WGS) with a net purchase of 430,900. Other recent insider transactions involving GeneDx Holdings Corp (WGS) include a net sale of 125,889 shares made by Kevin Feeley , a net sale of 298,346 shares made by Katherine Stueland , and a net sale of 911,631 shares made by Opko Health, Inc. .

In summary, during the past 3 months, insiders sold 153,660 shares of GeneDx Holdings Corp (WGS) in total and bought 100,000 shares, with a net sale of 53,660 shares. During the past 18 months, 2,400,710 shares of GeneDx Holdings Corp (WGS) were sold and 645,642 shares were bought by its insiders, resulting in a net sale of 1,755,068 shares.

GeneDx Holdings Corp (WGS)'s detailed insider trading history can be found in Insider Trading Tracker table.